| Followers | 843 |
| Posts | 123010 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Wednesday, October 26, 2022 4:36:28 PM
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent BMY News
- Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline • Business Wire • 05/21/2026 09:01:00 PM
- Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations • Business Wire • 05/20/2026 10:59:00 AM
- Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees • GlobeNewswire Inc. • 05/12/2026 08:01:00 PM
- Wall Street's Cardiac Bet: Where Diagnostics Meet the Money • PR Newswire (Canada) • 05/12/2026 12:30:00 PM
- Wall Street's Cardiac Bet: Where Diagnostics Meet the Money • PR Newswire (US) • 05/12/2026 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/08/2026 08:33:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 08:10:44 PM
- Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults • Business Wire • 05/08/2026 10:59:00 AM
- Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026 • Business Wire • 05/06/2026 10:59:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 09:11:18 PM
- Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026™ • Business Wire • 05/04/2026 10:59:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 03:44:13 PM
- Bristol Myers beats Q1 expectations and reaffirms full-year outlook • IH Market News • 04/30/2026 02:33:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 11:01:58 AM
- Bristol Myers Squibb Reports First Quarter Financial Results for 2026 • Business Wire • 04/30/2026 10:59:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 09:08:17 PM
- AstraZeneca Gains FDA Nod for SAPHNELO At-Home Injection in Lupus Care • IH Market News • 04/27/2026 01:46:12 PM
- AstraZeneca Secures FDA Approval for SAPHNELO Self-Injectable Pen in Lupus Treatment • UK Market News • 04/27/2026 12:50:37 PM
- Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company • Business Wire • 04/24/2026 10:59:00 AM
- Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration • PR Newswire (US) • 04/23/2026 12:00:00 PM
- Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2026 08:15:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:29:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:28:19 PM
